đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-06
Trial ID
NCT01506193
Treatments Being Tested
The purpose of this booster vaccination study is to evaluate the persistenc...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00135564
Treatments Being Tested
The purpose of this study is to compare the reactogenicity \& safety of Tri...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-12-11
Trial ID
NCT00317135
Treatments Being Tested
This study will evaluate the immunogenicity of the co-administration of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-30
Trial ID
NCT00352963
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335
This study has 2 phases, a vaccination phase and a long-term follow-up phas...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-07
Trial ID
NCT00427908
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
The purpose of the primary phase of the study is to demonstrate the non-inf...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-01
Trial ID
NCT00326118
The purpose of the study is to demonstrate consistent results in 3 producti...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08
Trial ID
NCT00317161
Treatments Being Tested